
Gertrude Elion
格特鲁德·埃利恩
Revolutionized Drug Development
Biography
Gertrude Elion developed a revolutionary approach to drug design that used differences in biochemistry between normal cells and pathogens. Her method led to treatments for leukemia, herpes, malaria, gout, and organ transplant rejection. She shared the 1988 Nobel Prize in Physiology or Medicine. Despite never completing a PhD — she was denied admission to graduate programs because she was a woman — her innovations saved millions of lives.
格特鲁德·埃利恩开发了一种革命性的药物设计方法,利用正常细胞和病原体之间的生化差异。她的方法导致了白血病、疱疹、疟疾、痛风和器官移植排斥反应的治疗方案。她分享了1988年诺贝尔生理学或医学奖。尽管从未完成博士学位——她因为是女性而被拒绝进入研究生项目——她的创新挽救了数百万人的生命。
Key Achievements
Nobel Prize in Physiology or Medicine (1988)
诺贝尔生理学或医学奖(1988年)
Developed treatments for leukemia, herpes, and malaria
开发了白血病、疱疹和疟疾的治疗方法
Revolutionized rational drug design methodology
革新了理性药物设计方法论
References & Citations
- Wikipedia: Gertrude Elion — https://en.wikipedia.org/wiki/Gertrude_B._Elion
- Nobel Prize: Gertrude B. Elion — https://www.nobelprize.org/prizes/medicine/1988/elion/



